An animal model of glomerular light-chain-associated amyloidogenesis depicts the crucial role of lysosomes

In vitro and ex vivo studies have elucidated the step-by-step process whereby some physicochemically abnormal light chains are processed by mesangial cells to form amyloid fibrils. Although crucial steps in the cascade of events have been determined, these findings have not been reproduced in vivo....

Full description

Saved in:
Bibliographic Details
Published inKidney international Vol. 86; no. 4; pp. 738 - 746
Main Authors Teng, Jiamin, Turbat-Herrera, Elba A, Herrera, Guillermo A
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2014
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In vitro and ex vivo studies have elucidated the step-by-step process whereby some physicochemically abnormal light chains are processed by mesangial cells to form amyloid fibrils. Although crucial steps in the cascade of events have been determined, these findings have not been reproduced in vivo. This has led to some doubts as to the significance and clinical application of the information that has been deciphered. Here, we developed an animal model which uses mice injected with amyloidogenic light chains purified from the urine of patients with biopsy-proven, light-chain-associated glomerular amyloidosis which validated in vitro/ex vivo findings. This animal model showed internalization of the light chains utilizing caveolae followed by trafficking to the mature lysosomal compartment where fibrils were formed. This model permits evaluation of mesangial amyloidogenesis for prolonged periods of time, is potentially useful to test maneuvers to modulate events that take place, and can be used to design novel therapeutic interventions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0085-2538
1523-1755
DOI:10.1038/ki.2014.122